The problem

Only a few diabetics in developing countries have the opportunity to take their insulin in an insulin pen used by those diabetics in affluent countries. Instead, they are relegated to using traditional syringes and needles, which are cheaper but difficult to use safely.

We wish to change this.

Changing the world together

Building on a grant from the Danish “Innovationsfonden”, we seek additional support for maturing a patented concept that combines elements of known and new technology into a new, safe and cheaper type of insulin pen.

Of the world's 425 million diabetics, 300 million live in developing countries, where the incidence of diabetes is increasing at an alarming rate [IDF, 2017]. About 13 million resource poor people with diabetes buy insulin in vials. [IMS, 2017]. The vast majority cannot afford to buy insulin in the insulin pens used in most middle- and high-income countries, and health systems do not usually offer this option.

We want to partner with foundations and companies that will help create a better future for the many people who do not have access to modern medical devices, thereby contributing to the achievement of UN's World Goal 3 on improving health for all.

How the we change the world for vulnerable populations with diabetes

The GO-Pen device creates access to a new insulin pen combining established mechanisms (which it has the rights and IP to exploit) with technical innovations to develop a significantly cheaper product. The GO-Pen combines a reusable unit that accurately doses insulin held in a capsule that can be refilled from vials. This eliminates the need for syringes. The benefits are, 1) a quicker, more discrete injection, 2) fewer life-threatening hypos, 3) reduced cost of training healthcare professionals, 4) ease of use and higher adherence, 5) reduced risk of complications, 6) reduced cost; and 7) reduced hazardous waste and CO2 emissions

This device will help create a better future for the many people who do not have access to modern insulin pens.